Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|December 6, 2021
Prevalence of Chronic Polypharmacy in Community-Dwelling Elderly People in Poland: Analysis of National Real-World Database Helps to Identify High Risk GroupPrzemysław Kardas, Aneta Lichwierowicz, Filip Urbański, et al.
BMC Endocrine Disorders|October 14, 2015
Drug-related risk of severe hypoglycaemia in observational studies: a systematic review and meta-analysisMarcin Czech, Elżbieta Rdzanek, Justyna Pawęska, et al.
Frontiers in Public Health|September 9, 2021
Do Advanced Therapies Have a Future in the Low- and Middle-Income Countries - The Case of Bulgaria, Romania, and PolandMaria Kamusheva, Adina Turcu-Stiolica, Jakub Gierczyński, et al.
Przeglad Epidemiologiczny|July 9, 2011
[Cost of lost productivity in pharmacoeconomics analysis. Part II. Survey in the expert group]Witold Wrona, Tomasz Hermanowski, Michał Jakubczyk, et al.
Frontiers in Public Health|December 22, 2025
Public spending on immunisation in PolandMichał Seweryn, Joanna Augustyńska, Justyna Kopel, et al.
Journal of Cardiovascular Development and Disease|July 26, 2024
Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular DiseasesAndrás Inotai, Zoltán Kaló, Zsuzsanna Petykó, et al.
Ginekologia Polska|October 16, 2024
Cost-effectiveness of nonavalent vs bivalent HPV vaccine in Polish settingMichal Jakubczyk, Joanna Bieganska, Katarzyna Kowalczuk, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 17, 2021
Patient care efficiency in primary healthcare - pilot study in Medical and Diagnostical CentreArtur Prusaczyk, Magdalena Bogdan, Paweł Żuk, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 24, 2019
Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in PolandMelania Brzozowska, Waldemar Wierzba, Sylwia Szafraniec-Buryło, et al.
Pageof 7